Annual ROE
15.63%
+7.02%+81.53%
31 December 2023
Summary:
AstraZeneca annual return on equity is currently 15.63%, with the most recent change of +7.02% (+81.53%) on 31 December 2023. During the last 3 years, it has fallen by -5.51% (-26.06%). AZN annual ROE is now -80.63% below its all-time high of 80.71%, reached on 31 December 1991.AZN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
16.71%
-0.16%-0.95%
30 September 2024
Summary:
AstraZeneca quarterly return on equity is currently 16.71%, with the most recent change of -0.16% (-0.95%) on 30 September 2024. Over the past year, it has increased by +0.57% (+3.53%). AZN quarterly ROE is now -71.21% below its all-time high of 58.04%, reached on 31 December 1998.AZN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +81.5% | +3.5% |
| 3 y3 years | -26.1% | +125.5% |
| 5 y5 years | +11.3% | +11.1% |
AZN ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -26.1% | +3712.2% | -1.6% | +545.6% |
| 5 y | 5 years | -26.1% | +3712.2% | -41.5% | +545.6% |
| alltime | all time | -80.6% | +3712.2% | -71.2% | +545.6% |
AstraZeneca ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 16.71%(-0.9%) |
| June 2024 | - | 16.87%(-0.3%) |
| Mar 2024 | - | 16.92%(+6.1%) |
| Dec 2023 | 15.63%(+81.5%) | 15.95%(-1.2%) |
| Sept 2023 | - | 16.14%(-5.0%) |
| June 2023 | - | 16.99%(+30.3%) |
| Mar 2023 | - | 13.04%(+45.9%) |
| Dec 2022 | 8.61%(+2000.0%) | 8.94%(+63.7%) |
| Sept 2022 | - | 5.46%(-245.6%) |
| June 2022 | - | -3.75%(+2.7%) |
| Mar 2022 | - | -3.65%(-911.1%) |
| Dec 2021 | 0.41%(-98.1%) | 0.45%(-93.9%) |
| Sept 2021 | - | 7.41%(-71.3%) |
| June 2021 | - | 25.81%(-9.7%) |
| Mar 2021 | - | 28.58%(+24.7%) |
| Dec 2020 | 21.14%(+126.8%) | 22.92%(+24.4%) |
| Sept 2020 | - | 18.43%(+18.8%) |
| June 2020 | - | 15.52%(+37.8%) |
| Mar 2020 | - | 11.26%(+17.0%) |
| Dec 2019 | 9.32%(-33.7%) | 9.62%(-36.0%) |
| Sept 2019 | - | 15.04%(-5.2%) |
| June 2019 | - | 15.87%(-9.8%) |
| Mar 2019 | - | 17.59%(+19.3%) |
| Dec 2018 | 14.05%(-22.0%) | 14.75%(-9.3%) |
| Sept 2018 | - | 16.26%(-7.2%) |
| June 2018 | - | 17.53%(-3.9%) |
| Mar 2018 | - | 18.24%(-4.1%) |
| Dec 2017 | 18.02%(-9.4%) | 19.01%(-17.1%) |
| Sept 2017 | - | 22.93%(-8.6%) |
| June 2017 | - | 25.08%(+16.0%) |
| Mar 2017 | - | 21.62%(+1.5%) |
| Dec 2016 | 19.89%(+34.3%) | 21.30%(+43.1%) |
| Sept 2016 | - | 14.88%(+15.5%) |
| June 2016 | - | 12.88%(-22.6%) |
| Mar 2016 | - | 16.64%(+6.9%) |
| Dec 2015 | 14.81%(+157.6%) | 15.56%(+70.2%) |
| Sept 2015 | - | 9.14%(+50.8%) |
| June 2015 | - | 6.06%(-4.7%) |
| Mar 2015 | - | 6.36%(+10.2%) |
| Dec 2014 | 5.75%(-46.9%) | 5.77%(+24.1%) |
| Sept 2014 | - | 4.65%(-47.8%) |
| June 2014 | - | 8.90%(-0.9%) |
| Mar 2014 | - | 8.98%(-18.1%) |
| Dec 2013 | 10.83%(-58.9%) | 10.97%(-44.7%) |
| Sept 2013 | - | 19.85%(-6.5%) |
| June 2013 | - | 21.22%(-15.0%) |
| Mar 2013 | - | 24.97%(-9.1%) |
| Dec 2012 | 26.32%(-37.8%) | 27.46%(+1.6%) |
| Sept 2012 | - | 27.02%(-23.2%) |
| June 2012 | - | 35.18%(-5.7%) |
| Mar 2012 | - | 37.32%(-11.6%) |
| Dec 2011 | 42.31%(+16.2%) | 42.24%(-2.9%) |
| Sept 2011 | - | 43.52%(+21.5%) |
| June 2011 | - | 35.81%(-2.5%) |
| Mar 2011 | - | 36.72%(+0.0%) |
| Dec 2010 | 36.41%(-10.7%) | 36.71%(-2.7%) |
| Sept 2010 | - | 37.72%(-10.5%) |
| June 2010 | - | 42.14%(-2.1%) |
| Mar 2010 | - | 43.03%(+2.9%) |
| Dec 2009 | 40.79%(+3.6%) | 41.83%(-1.1%) |
| Sept 2009 | - | 42.29%(+1.4%) |
| June 2009 | - | 41.72%(-2.5%) |
| Mar 2009 | - | 42.80%(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | 39.39%(+6.8%) | 39.02%(-2.0%) |
| Sept 2008 | - | 39.81%(+5.0%) |
| June 2008 | - | 37.92%(+0.7%) |
| Mar 2008 | - | 37.67%(-0.3%) |
| Dec 2007 | 36.89%(-11.2%) | 37.77%(-3.1%) |
| Sept 2007 | - | 38.96%(-3.7%) |
| June 2007 | - | 40.47%(-2.2%) |
| Mar 2007 | - | 41.39%(+1.8%) |
| Dec 2006 | 41.52%(+24.3%) | 40.66%(+0.7%) |
| Sept 2006 | - | 40.37%(+4.9%) |
| June 2006 | - | 38.50%(+5.5%) |
| Mar 2006 | - | 36.49%(+6.7%) |
| Dec 2005 | 33.39%(+26.5%) | 34.19%(+6.4%) |
| Sept 2005 | - | 32.13%(+1.2%) |
| June 2005 | - | 31.74%(+8.5%) |
| Mar 2005 | - | 29.24%(+5.9%) |
| Dec 2004 | 26.40%(+6.9%) | 27.60%(+7.5%) |
| Sept 2004 | - | 25.68%(+10.0%) |
| June 2004 | - | 23.35%(+3.9%) |
| Mar 2004 | - | 22.47%(-6.3%) |
| Dec 2003 | 24.69%(-9.2%) | 23.98%(+3.8%) |
| Sept 2003 | - | 23.11%(+0.5%) |
| June 2003 | - | 22.99%(-7.5%) |
| Mar 2003 | - | 24.86%(-5.3%) |
| Dec 2002 | 27.20%(-12.1%) | 26.26%(-13.1%) |
| Sept 2002 | - | 30.22%(-5.1%) |
| June 2002 | - | 31.83%(-0.4%) |
| Mar 2002 | - | 31.95%(+4.0%) |
| Dec 2001 | 30.94%(+21.1%) | 30.73%(+11.4%) |
| Sept 2001 | - | 27.59%(+3.6%) |
| June 2001 | - | 26.62%(+0.3%) |
| Mar 2001 | - | 26.55%(+6.4%) |
| Dec 2000 | 25.55%(+138.3%) | 24.95%(+46.2%) |
| Sept 2000 | - | 17.06%(+11.0%) |
| June 2000 | - | 15.37%(+19.6%) |
| Mar 2000 | - | 12.85%(+9.3%) |
| Dec 1999 | 10.72%(-70.0%) | 11.76%(-66.6%) |
| Sept 1999 | - | 35.20%(-12.3%) |
| June 1999 | - | 40.15%(+0.3%) |
| Mar 1999 | - | 40.02%(-31.0%) |
| Dec 1998 | 35.75%(+7.9%) | 58.04%(+35.0%) |
| Sept 1998 | - | 42.99%(-11.4%) |
| June 1998 | - | 48.53%(+27.9%) |
| Mar 1998 | - | 37.95%(-10.0%) |
| Dec 1997 | 33.13%(+0.8%) | 42.15%(-12.1%) |
| Sept 1997 | - | 47.95%(+3.7%) |
| June 1997 | - | 46.24%(+3.7%) |
| Mar 1997 | - | 44.59%(-11.4%) |
| Dec 1996 | 32.88%(+82.5%) | 50.34%(+46.7%) |
| Sept 1996 | - | 34.31%(+11.6%) |
| June 1996 | - | 30.73%(+6.8%) |
| Mar 1996 | - | 28.77%(+1.6%) |
| Dec 1995 | 18.02%(-34.3%) | 28.32%(-20.8%) |
| Sept 1995 | - | 35.76%(-6.5%) |
| June 1995 | - | 38.23%(-9.9%) |
| Mar 1995 | - | 42.44%(+7.3%) |
| Dec 1994 | 27.44%(-46.3%) | 39.56%(+4.7%) |
| Sept 1994 | - | 37.78%(+4.7%) |
| June 1994 | - | 36.09%(+24.7%) |
| Mar 1994 | - | 28.94%(+0.7%) |
| Dec 1993 | 51.13%(+129.0%) | 28.75% |
| Dec 1992 | 22.33%(-72.3%) | - |
| Dec 1991 | 80.71%(+7.6%) | - |
| Dec 1990 | 75.00% | - |
FAQ
- What is AstraZeneca annual return on equity?
- What is the all time high annual ROE for AstraZeneca?
- What is AstraZeneca annual ROE year-on-year change?
- What is AstraZeneca quarterly return on equity?
- What is the all time high quarterly ROE for AstraZeneca?
- What is AstraZeneca quarterly ROE year-on-year change?
What is AstraZeneca annual return on equity?
The current annual ROE of AZN is 15.63%
What is the all time high annual ROE for AstraZeneca?
AstraZeneca all-time high annual return on equity is 80.71%
What is AstraZeneca annual ROE year-on-year change?
Over the past year, AZN annual return on equity has changed by +7.02% (+81.53%)
What is AstraZeneca quarterly return on equity?
The current quarterly ROE of AZN is 16.71%
What is the all time high quarterly ROE for AstraZeneca?
AstraZeneca all-time high quarterly return on equity is 58.04%
What is AstraZeneca quarterly ROE year-on-year change?
Over the past year, AZN quarterly return on equity has changed by +0.57% (+3.53%)